ANGEL SABO: Open Payments
NPI 1699128538 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 48 payments from 14 companies in 2025. Trend: 2023 $1,654 · 2024 $925 · 2025 $967
Food & beverage: $874Education: $93
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $373 |
| Regeneron Healthcare Solutions, Inc. | 6 | $138 |
| United Therapeutics Corporation | 3 | $64 |
| Inspire Medical Systems, Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Verona Pharma, Inc. | 2 | $48 |
| Insmed, Inc. | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 1 | $39 |
| Amgen Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $31 |
Products named: NUCALA, DUPIXENT, INSPIRE, Ohtuvayre, Arikayce, ACTHAR, AIRSUPRA, Tyvaso.
Industry payments across OH — which companies pay providers there.
